Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

Clinical trial NCT00038558 · COMPLETED

Trial details

NCT number: NCT00038558
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hodgkin Disease

Start date: 2001-11-01
Primary completion: 2004-02-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.